Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

Data publikacji: 11 lip 2022

Zakres stron: 89 - 92

Otrzymano: 03 sty 2022

Przyjęty: 31 maj 2022

DOI: https://doi.org/10.2478/amma-2022-0011

Słowa kluczowe

insulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies

© 2022 Andrada Raluca Pop et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.